Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

OFIX

Orthofix Medical Inc

May 13 • 04:00PM ET

12.21

+0.03 0.25 %

Healthcare • Medical Devices • USA • Small • NASD

Peers: ATEC KIDS XTNT SIBN IART

| Held by: VTI IWM VXF IWN SCHA IHI VTWO DFMC DFAS DFAC

Index	RUT	P/E	-	EPS (ttm)	-1.50	Insider Own	3.03%	Shs Outstand	40.38M	Perf Week	0.16%
Market Cap	493.55M	Forward P/E	-	EPS next Y	-0.81	Insider Trans	28.57%	Shs Float	39.20M	Perf Month	-4.01%
Enterprise Value	634.94M	PEG	-	EPS next Q	-0.39	Inst Own	86.00%	Short Float	3.16%	Perf Quarter	-9.56%
Income	-60.01M	P/S	0.60	EPS this Y	51.93%	Inst Trans	-2.41%	Short Ratio	4.16	Perf Half Y	-18.76%
Sales	825.37M	P/B	1.13	EPS next Y	27.23%	ROA	-7.02%	Short Interest	1.24M	Perf YTD	-19.46%
Book/sh	10.78	P/C	4.08	EPS next 5Y	49.79%	ROE	-13.43%	52W High	16.99 -28.13%	Perf Year	-2.24%
Cash/sh	2.99	P/FCF	-	EPS past 3/5Y	-33.21% -	ROIC	-8.64%	52W Low	10.24 19.24%	Perf 3Y	-32.84%
Dividend Est.	-	EV/EBITDA	66.07	Sales past 3/5Y	21.30% 15.13%	Gross Margin	69.17%	Volatility	5.19% 4.75%	Perf 5Y	-70.73%
Dividend TTM	-	EV/Sales	0.77	EPS Y/Y TTM	59.39%	Oper. Margin	-5.67%	ATR (14)	0.57	Perf 10Y	-71.58%
Dividend Ex-Date	-	Quick Ratio	1.76	Sales Y/Y TTM	2.59%	Profit Margin	-7.27%	RSI (14)	51.78	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	2.87	EPS Q/Q	61.85%	SMA20	0.78%	Beta	0.80	Target Price	17.25
Payout	-	Debt/Eq	0.60	Sales Q/Q	1.58%	SMA50	1.12%	Rel Volume	0.83	Prev Close	12.18
Employees	1605	LT Debt/Eq	0.60	Earnings	May 05 BMO	SMA200	-12.05%	Avg Volume	297.80K	Price	12.21
IPO	Apr 24, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.53% 0.16%	Trades		Volume	246,111	Change	0.25%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-26	Initiated	TD Cowen	Hold	$14
Oct-28-25	Resumed	Stifel	Buy	$22
Jan-22-25	Initiated	Canaccord Genuity	Buy	$24
Nov-08-24	Upgrade	Stifel	Hold → Buy	$18 → $24
May-08-24	Upgrade	ROTH MKM	Neutral → Buy	$15 → $20
Oct-20-23	Initiated	ROTH MKM	Neutral	$12
Sep-12-23	Downgrade	Stifel	Buy → Hold
Sep-12-23	Downgrade	BTIG Research	Buy → Neutral
Jul-19-23	Resumed	BTIG Research	Buy	$27
Mar-04-22	Upgrade	Stifel	Hold → Buy	$41 → $45
Oct-20-20	Initiated	Stifel	Hold	$39
Oct-29-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$71 → $48
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
Jun-21-17	Initiated	BTIG Research	Buy	$52
Jun-14-17	Initiated	Ladenburg Thalmann	Buy	$53.25
May-23-17	Initiated	SunTrust	Buy	$49
Jul-10-15	Initiated	Sidoti	Buy
May-09-13	Downgrade	Mizuho	Buy → Neutral	$45 → $28
Jan-08-13	Reiterated	Mizuho	Buy	$47 → $45
Jun-21-10	Initiated	Boenning & Scattergood	Outperform	$45

Show Previous Ratings

May-06-26 07:00AM	Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE Innovation at POSNA 2026 Annual Meeting (Business Wire)
May-05-26 03:47PM	Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
12:50PM	Orthofix Medical Inc. Q1 2026 Earnings Call Summary (Moby)
07:28AM	Orthofix: Q1 Earnings Snapshot (Associated Press)
07:00AM	Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance (Business Wire)
07:00AM	Loading…
Apr-21-26 07:00AM	Orthofix to Report First Quarter 2026 Financial Results (Business Wire)
Apr-09-26 07:00AM	Orthofix Realigns Spine Leadership to Strengthen Focus and Execution (Business Wire)
Mar-11-26 12:31PM	Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Mar-02-26 10:22AM	Orthofix Medical Inc. (OFIX) Target Reduced at Canaccord Following Q4 Results and 2026 Outlook Update (Insider Monkey)
Feb-24-26 04:32PM	Orthofix Medical Inc. Q4 2025 Earnings Call Summary (Moby) -6.18%
04:02PM	Orthofix Medical Inc (OFIX) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com)
12:49PM	Orthofix Medical Q4 Earnings Call Highlights (MarketBeat)
09:40AM	Orthofix (OFIX) Q4 Earnings and Revenues Lag Estimates (Zacks)
07:52AM	Orthofix: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance (Business Wire)
06:53PM	Loading…
Feb-20-26 06:53PM	TripAdvisor, Orthofix Medical, and More Stocks See Action From Activist Investors (Barrons.com)
Feb-19-26 05:20PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Feb-10-26 07:00AM	Orthofix to Participate in Upcoming Investor Conferences (Business Wire)
Feb-03-26 07:00AM	Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results (Business Wire)
Jan-09-26 07:00AM	Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors (Business Wire)
Nov-04-25 04:08PM	Orthofix Medical Inc (OFIX) Q3 2025 Earnings Call Highlights: Strong Growth in US Spine and ... (GuruFocus.com) -7.41%
08:20AM	Orthofix (OFIX) Beats Q3 Earnings and Revenue Estimates (Zacks)
07:19AM	Orthofix: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Orthofix Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-03-25 07:56AM	Orthofix Medical Inc (OFIX) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-25 05:42PM	Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors (Barrons.com)
Oct-15-25 07:00AM	Orthofix to Participate in Upcoming Investor Conferences (Business Wire)
Oct-14-25 07:00AM	Orthofix to Report Third Quarter 2025 Financial Results (Business Wire)
Oct-07-25 11:40AM	FMS vs. OFIX: Which Stock Is the Better Value Option? (Zacks)
Oct-03-25 06:49PM	Orthofix Medical, Central Pacific Financial, and More Stocks See Action From Activist Investors (Barrons.com)
10:13AM	Loading…
Oct-02-25 10:13AM	ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7 (Zacks)
Sep-15-25 09:12AM	Do You Believe in the Growth Potential of Orthofix Medical (OFIX)? (Insider Monkey)
Aug-13-25 12:08PM	Barrington Lifts PT on Orthofix Medical (OFIX) to $17 From $16, Keeps an Overweight Rating (Insider Monkey)
Aug-07-25 11:40AM	FMS vs. OFIX: Which Stock Should Value Investors Buy Now? (Zacks)
Aug-05-25 08:25AM	Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates (Zacks) +13.46%
07:25AM	Orthofix: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Orthofix Reports Second Quarter 2025 Financial Results (Business Wire)
Aug-04-25 10:00AM	Orthofix Medical Inc (OFIX) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
07:40AM	Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates (Zacks)
Jul-16-25 07:00AM	Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Jul-15-25 07:00AM	Orthofix to Report Second Quarter 2025 Financial Results (Business Wire)
Jun-17-25 07:00AM	Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System (Business Wire)
May-07-25 03:09AM	Orthofix Medical Inc (OFIX) Q1 2025 Earnings Call Highlights: Strong Growth in Orthopedics and ... (GuruFocus.com)
12:09AM	Q1 2025 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents)
May-06-25 08:35AM	Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -10.93%
07:36AM	Orthofix: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Orthofix Reports First Quarter 2025 Financial Results (Business Wire)
May-05-25 10:08AM	Orthofix Medical Inc (OFIX) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-22-25 05:15PM	Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-18-25 02:06PM	Six Flags, Rapid7, and More Stocks See Action From Activist Investors (Barrons.com)
Apr-15-25 08:00AM	Orthofix to Report First Quarter 2025 Financial Results (Business Wire)
Mar-19-25 08:00AM	Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System (Business Wire)
Mar-12-25 08:00AM	Orthofix Announces Appointment of Vickie Capps to Board of Directors (Business Wire)
Mar-07-25 07:51AM	Orthofixs fired execs lewd, graphic texts surface in legal battle (CFO Dive)
Mar-03-25 07:00AM	Orthofix to Participate in the 37th Annual Roth Conference (Business Wire)
Feb-26-25 02:18AM	Q4 2024 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents)
02:07AM	Orthofix Medical Inc (OFIX) Q4 2024 Earnings Call Highlights: Record Growth and Strategic Shifts (GuruFocus.com)
Feb-25-25 08:35AM	Orthofix (OFIX) Q4 Earnings Lag Estimates (Zacks)
07:41AM	Orthofix: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance (Business Wire)
01:44AM	Orthofix Medical Inc (OFIX) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-17-25 07:05AM	Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference (Business Wire)
Jan-28-25 07:00AM	Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results (Business Wire)
Nov-12-24 07:05AM	Orthofix to Participate in Upcoming Investor Conferences (Business Wire)
Nov-08-24 07:32AM	Orthofix Reports Q3 Sales Growth and New Financial Targets (TipRanks) +6.53%
02:14AM	Orthofix Medical Inc (OFIX) Q3 2024 Earnings Call Highlights: Strong Growth in US Spine ... (GuruFocus.com)
Nov-07-24 08:25AM	Orthofix (OFIX) Q3 Earnings Surpass Estimates (Zacks)
07:23AM	Orthofix: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets (Business Wire)
07:05AM	Orthofix Announces New Term Loan (Business Wire)
Nov-06-24 07:30AM	What To Expect From Orthofix Medical Inc (OFIX) Q3 2024 Earnings (GuruFocus.com)
Oct-21-24 07:00AM	Orthofix to Participate in Stifel 2024 Healthcare Conference (Business Wire)
Oct-10-24 07:00AM	Orthofix to Report Third Quarter 2024 Financial Results (Business Wire)
Oct-09-24 12:34PM	Shareholders of Orthofix Medical Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights OFIX (GlobeNewswire)
Sep-27-24 05:45AM	Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - OFIX (PR Newswire)
Sep-23-24 07:00AM	Orthofix Highlights New Products and Announces Presentation of Data Supporting the Adjunct Use of Bone Growth Therapy for Lumbar Spine Fusion at North American Spine Society Annual Meeting (Business Wire)
Sep-13-24 05:45AM	Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - OFIX (PR Newswire)
Aug-30-24 10:22AM	Orthofix Medical Inc (NASDAQ:OFIX) A Bull Case Theory (Insider Monkey)
Aug-15-24 05:52PM	Patrick Fisher Joins Orthofix as President of Global Orthopedics Business (Business Wire)
Aug-07-24 06:09AM	Q2 2024 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-06-24 08:15AM	Orthofix (OFIX) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +19.53%
07:17AM	Orthofix: Q2 Earnings Snapshot (Associated Press Finance)
07:03AM	Orthofix Reports Second Quarter 2024 Results and Raises Full-Year 2024 Financial Guidance (Business Wire)
Jul-17-24 07:00AM	Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference (Business Wire)
Jul-16-24 07:00AM	Orthofix Names Stephanie Walsh Chief Human Resources Officer (Business Wire)
Jul-10-24 12:13PM	Orthofix Medical's (OFIX) Fitbone System Gets FDA Clearance (Zacks)
06:32AM	Orthofix obtains FDA clearance for Fitbone system (Medical Device Network)
Jul-09-24 07:00AM	Orthofix to Report Second Quarter 2024 Financial Results (Business Wire)
07:00AM	Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System (Business Wire)
Jun-24-24 07:00AM	Michael Finegan Named Chair of the Orthofix Board of Directors (Business Wire)
03:11AM	Orthofixs president of global orthopedics resigns (MedTech Dive)
Jun-18-24 07:00AM	Aviva McPherron Joins Orthofix as President of Global Operations and Quality (Business Wire)
Jun-11-24 07:00AM	Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine (Business Wire)
May-23-24 07:00AM	Orthofix Names Max Reinhardt President of Global Spine Business (Business Wire)
May-16-24 07:15AM	Orthofix Wins Best Patient Experience Solution Award in 2024 MedTech Breakthrough Awards Program (GlobeNewswire)
May-13-24 11:18AM	Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance (Zacks)
May-09-24 07:00AM	Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail (Business Wire)
May-08-24 01:03PM	Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript (Insider Monkey) +7.27%
07:43AM	Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target (MT Newswires)
03:16AM	Orthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HENNEMAN JOHN B III	Director	May 07 '26	Buy	12.26	5,000	61,295	90,809	May 08 04:52 PM
Engine Capital Management, LP	10% Owner	May 05 '26	Buy	11.99	112,950	1,354,587	3,783,131	May 07 06:15 PM
Engine Capital Management, LP	10% Owner	May 06 '26	Buy	12.23	41,946	512,916	3,821,285	May 07 06:15 PM
Engine Capital Management, LP	10% Owner	May 07 '26	Buy	12.18	30,000	365,425	3,848,573	May 07 06:15 PM
Cedron Jorge Andres	CLO	Apr 16 '26	Sale	12.82	3,743	47,985	59,006	Apr 20 04:11 PM
Vitale Lucas	CP&BOO	Mar 17 '26	Sale	11.92	4,269	50,886	160,449	Mar 19 04:31 PM
CAPPS VICKIE L	Director	Mar 09 '26	Buy	12.48	2,500	31,200	25,085	Mar 10 04:13 PM
CAPPS VICKIE L	Director	Mar 10 '26	Buy	12.45	2,500	31,124	27,585	Mar 10 04:13 PM
Andrews Julie	CFO	Mar 04 '26	Sale	12.92	2,425	31,322	91,109	Mar 06 04:20 PM
Andrews Julie	CFO	Mar 05 '26	Sale	12.55	2,363	29,658	88,746	Mar 06 04:20 PM
Vitale Lucas	CP&BOO	Mar 04 '26	Sale	12.92	1,171	15,125	165,859	Mar 06 04:19 PM
Vitale Lucas	CP&BOO	Mar 05 '26	Sale	12.55	1,141	14,320	164,718	Mar 06 04:19 PM
Calafiore Massimo	President & CEO	Mar 04 '26	Sale	12.92	6,189	79,939	326,167	Mar 06 04:17 PM
Calafiore Massimo	President & CEO	Mar 05 '26	Sale	12.55	6,031	75,694	320,136	Mar 06 04:17 PM
Fisher Patrick	President, Global Limb Recon	Mar 04 '26	Sale	12.92	778	10,049	51,391	Mar 06 04:17 PM
Fisher Patrick	President, Global Limb Recon	Mar 05 '26	Sale	12.55	758	9,514	50,633	Mar 06 04:17 PM
McPherron Aviva	Pres, Global Ops & Qual	Mar 04 '26	Sale	12.92	1,296	16,740	69,116	Mar 06 04:16 PM
McPherron Aviva	Pres, Global Ops & Qual	Mar 05 '26	Sale	12.55	1,263	15,852	67,853	Mar 06 04:16 PM
REINHARDT MAX	President, Global Spine	Mar 04 '26	Sale	12.92	1,080	13,950	26,401	Mar 06 04:14 PM
REINHARDT MAX	President, Global Spine	Mar 05 '26	Sale	12.55	1,053	13,216	25,348	Mar 06 04:14 PM
Cedron Jorge Andres	CLO	Mar 04 '26	Sale	12.92	1,405	18,147	64,119	Mar 06 04:14 PM
Cedron Jorge Andres	CLO	Mar 05 '26	Sale	12.55	1,370	17,195	62,749	Mar 06 04:14 PM
Engine Capital Management, LP	10% Owner	Feb 24 '26	Buy	12.55	124,797	1,565,641	3,663,133	Feb 26 05:48 PM
Engine Capital Management, LP	10% Owner	Feb 25 '26	Buy	12.96	13,061	169,315	3,673,092	Feb 26 05:48 PM
Andrews Julie	CFO	Jan 16 '26	Sale	14.38	4,873	70,074	58,039	Jan 21 04:09 PM
Calafiore Massimo	President & CEO	Jan 09 '26	Sale	15.82	9,600	151,906	227,034	Jan 13 05:46 PM
Calafiore Massimo	President & CEO	Jan 12 '26	Sale	15.21	9,797	149,050	217,237	Jan 13 05:46 PM
Fisher Patrick	President, Global Orthopedics	Aug 18 '25	Sale	14.21	1,996	28,363	30,116	Aug 20 04:08 PM
Engine Capital Management, LP	10% Owner	Jul 02 '25	Buy	11.11	1,250	13,881	3,546,057	Jul 07 05:43 PM
McPherron Aviva	Pres, Global Ops & Qual	Jun 18 '25	Sale	10.51	3,728	39,181	46,322	Jun 23 04:15 PM
REINHARDT MAX	President, Global Spine	Jun 11 '25	Sale	11.64	1,643	19,125	27,481	Jun 13 04:10 PM
Bazaar Alan Lee	Director	Jun 04 '25	Buy	10.92	2,250	24,570	30,983	Jun 05 05:11 PM

ANIK Anika Therapeutics Inc daily Stock Chart

Peers: VCEL XTNT XERS ATEC ENTA

| Held by: VTI IWM VXF IWN AVUV SCHA VTWO DFMC DFAS DFSV

Index	RUT	P/E	-	EPS (ttm)	-0.79	Insider Own	5.59%	Shs Outstand	13.36M	Perf Week	-2.12%
Market Cap	196.93M	Forward P/E	95.48	EPS next Y	0.15	Insider Trans	2.37%	Shs Float	12.56M	Perf Month	-3.27%
Enterprise Value	181.65M	PEG	1.17	EPS next Q	-0.08	Inst Own	95.52%	Short Float	4.40%	Perf Quarter	44.39%
Income	-11.06M	P/S	1.69	EPS this Y	-209.09%	Inst Trans	0.41%	Short Ratio	4.09	Perf Half Y	46.97%
Sales	116.26M	P/B	1.48	EPS next Y	229.17%	ROA	-5.99%	Short Interest	0.55M	Perf YTD	54.01%
Book/sh	10.02	P/C	4.80	EPS next 5Y	81.71%	ROE	-7.85%	52W High	16.24 -8.87%	Perf Year	19.26%
Cash/sh	3.08	P/FCF	189.35	EPS past 3/5Y	9.40% 14.76%	ROIC	-7.02%	52W Low	7.87 88.05%	Perf 3Y	-41.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-10.28% -2.86%	Gross Margin	58.59%	Volatility	3.05% 5.63%	Perf 5Y	-65.32%
Dividend TTM	-	EV/Sales	1.56	EPS Y/Y TTM	79.57%	Oper. Margin	-10.54%	ATR (14)	0.76	Perf 10Y	-66.14%
Dividend Ex-Date	-	Quick Ratio	3.37	Sales Y/Y TTM	-15.41%	Profit Margin	-9.52%	RSI (14)	50.98	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.46	EPS Q/Q	-9.65%	SMA20	-0.65%	Beta	0.19	Target Price	17.50
Payout	-	Debt/Eq	0.19	Sales Q/Q	13.16%	SMA50	0.70%	Rel Volume	0.34	Prev Close	14.68
Employees	235	LT Debt/Eq	0.18	Earnings	Apr 29 BMO	SMA200	36.50%	Avg Volume	135.11K	Price	14.80
IPO	May 03, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	485.71% 5.22%	Trades		Volume	45,959	Change	0.82%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-25	Initiated	B. Riley Securities	Buy	$21
Nov-01-24	Reiterated	Barrington Research	Outperform	$37 → $25
Aug-14-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$24
Mar-07-23	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-09-22	Upgrade	Barrington Research	Mkt Perform → Outperform	$31
Oct-14-22	Resumed	Stephens	Equal-Weight	$26
Mar-09-22	Downgrade	Stephens	Overweight → Equal-Weight	$35
Mar-09-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-16-21	Initiated	Stephens	Overweight	$55
Jul-16-21	Initiated	UBS	Neutral	$46
Dec-16-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$43
May-08-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-21-20	Upgrade	Sidoti	Neutral → Buy	$61
Jan-10-20	Upgrade	First Analysis Sec	Outperform → Strong Buy	$65
Nov-05-19	Initiated	BWS Financial	Sell	$29
Sep-24-19	Reiterated	Barrington Research	Outperform	$49 → $58
Sep-23-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$54
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Strong Buy	$37 → $54
Feb-22-19	Downgrade	Sidoti	Buy → Neutral	$56 → $41
Feb-22-19	Downgrade	First Analysis Sec	Outperform → Neutral	$41 → $37

Show Previous Ratings

Apr-29-26 12:50PM	Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary (Moby) -18.81%
07:14AM	Anika: Q1 Earnings Snapshot (Associated Press)
07:05AM	Anika Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-15-26 04:01PM	Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 (GlobeNewswire)
Apr-07-26 03:35PM	Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization (Exec Edge)
05:00PM	Loading…
Apr-03-26 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-03-26 03:29AM	Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference (MarketBeat)
Feb-27-26 08:30AM	Anika Therapeutics, Inc. Q4 2025 Earnings Call Summary (Moby) +12.28%
Feb-26-26 04:09PM	Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ... (GuruFocus.com) +16.91%
12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
10:59AM	Anika Therapeutics Q4 Earnings Call Highlights (MarketBeat)
07:35AM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-18-26 04:01PM	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference (GlobeNewswire)
Feb-12-26 04:01PM	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 (GlobeNewswire)
07:00AM	Loading…
Jan-08-26 07:00AM	Anika Therapeutics Announces Leadership Transition (GlobeNewswire)
Nov-06-25 06:00PM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... (GuruFocus.com)
Nov-05-25 08:25AM	Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates (Zacks)
07:22AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study (GlobeNewswire)
Nov-04-25 08:43AM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-23-25 04:01PM	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 (GlobeNewswire)
Sep-19-25 06:50AM	Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? (Zacks)
Sep-05-25 05:00AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-29-25 09:55AM	Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High? (Zacks)
Aug-20-25 12:00PM	Anika (ANIK) Upgraded to Buy: Here's What You Should Know (Zacks)
Jul-30-25 08:15AM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -27.42%
07:21AM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Second Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Loading…
07:00AM	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast Cartilage Repair Scaffold and Provides Program Update (GlobeNewswire)
Jul-29-25 10:04AM	Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:15AM	uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-21-25 10:11AM	Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? (Zacks)
Jul-16-25 04:01PM	Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 (GlobeNewswire)
Jul-03-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-05-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-12-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:29AM	Company News for May 12, 2025 (Zacks)
May-10-25 03:04AM	Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... (GuruFocus.com)
May-09-25 08:35AM	Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -21.03%
07:44AM	Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 (RTT News)
07:28AM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 09:45AM	Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result (GuruFocus.com)
09:05AM	Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-07-25 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
May-05-25 09:28AM	Is the Options Market Predicting a Spike in Anika Therapeutics Stock? (Zacks)
Apr-25-25 09:00AM	Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 (GlobeNewswire)
Apr-07-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.60%
Apr-03-25 08:44AM	Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? (Zacks)
Mar-13-25 06:43AM	Q4 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -11.10%
03:09AM	Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Mar-12-25 05:25PM	Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-07-25 06:00AM	Anika Completes Divestiture of Parcus Medical (GlobeNewswire)
Mar-01-25 06:42AM	Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now? (Insider Monkey)
Feb-26-25 08:00AM	Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 (GlobeNewswire)
Feb-25-25 08:00AM	Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference (GlobeNewswire)
Dec-23-24 04:01PM	Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-22-24 04:16PM	Anika To Participate in December 2024 Investor Conferences (GlobeNewswire)
Nov-01-24 03:07AM	Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com)
Oct-31-24 11:00AM	Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics (PR Newswire) -30.67%
08:25AM	Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:18AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2024 Financial Results (GlobeNewswire)
07:00AM	Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical (GlobeNewswire)
Oct-30-24 09:19AM	Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-17-24 04:01PM	Anika Announces Third Quarter 2024 Results Conference Call Date (GlobeNewswire)
Oct-09-24 06:04PM	Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-04-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-09-24 04:45PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-09-24 07:41AM	Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? (Insider Monkey)
Aug-08-24 06:35PM	Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates (Zacks)
05:27PM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
Jul-25-24 09:00AM	Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-16-24 07:19AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-11-24 08:30AM	Anika Announces Full Market Release of the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs (GlobeNewswire)
Jul-01-24 10:35AM	Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research (GlobeNewswire)
Jun-07-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-28-24 04:05PM	Anika Enters into Cooperation Agreement with Caligan Partners (GlobeNewswire)
May-09-24 12:22PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript (Insider Monkey) -11.28%
10:59AM	Q1 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-08-24 08:57PM	ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:40PM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM	Anika Announces CFO Transition (GlobeNewswire)
04:05PM	Anika Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-03-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-18-24 04:01PM	Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (GlobeNewswire)
Apr-02-24 08:00AM	Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-16-24 03:15PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 08:18AM	Q4 2023 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-13-24 04:47PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HENNEMAN JOHN B III	Director	May 01 '26	Buy	14.66	5,000	73,320	54,871	May 04 08:34 AM
Griffin Stephen D.	President and CEO	Apr 30 '26	Buy	12.29	12,200	149,881	36,163	Apr 30 05:22 PM
Griffin Stephen D.	EVP, CFO & COO	Jun 03 '25	Option Exercise	0.00	12,840	0	13,640	Jun 05 05:01 PM

OFIX

Orthofix Medical Inc

ANIK

Anika Therapeutics Inc

Upgrade your Finviz experience